2Cobb Stephanic L.Effective interventions for lifestyle change after myocardial infarction or coronary artery revascularization[J].AANP,2006;18(1):31-9.
3Watson K.Managing cardio metabolic risks:an evolving approach to patient care critical pathways in cardiology[J].EBM,2007;6(1):5-14.
2Piegas LS, Flather M, Pogue J,et al. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. Am J Cardiol,1999,84: 7M-12M.
3Newby LK, Bhapkar MV, White HD,et al. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. Eur Heart J, 2003,24:172-181.
4Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation,1998,97: 1195-1206.
5Cohen M, Demers C, Gurfinkel EP,et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxparin in Non-Q-wave Coronary Events Study Group. N Engl J Med,1997,337: 447-452.
6Spencer FA, Santopinto JJ, Gore JM, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol,2002,90:1056-1061.
7Chang WC, Harrington RA, Simoons ML, et al. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. Eur Heart J,2002 ,23:1102-1111.
8Gurfinkel EP, J Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol,1995,26: 313-318.
9The SYNERGY Executive Committee. Superior Yield of the New strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa inhibitors. The SYNERGY trial: study design and rationale. Am Heart J,2002,143:952-960.
10The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med,2000,342: 145-153.
